- Pharmaceutical Executive-10-01-2022
- Volume 42
- Issue 10
R&D’s Financial Focus
Top hubs continue to perform despite financial uncertainty in other industries.
With short-term financial considerations hitting all industries worldwide, the pharmaceutical R&D ecosystems living within the US borders are still thriving based on well-known keys to success. It does not seem that long ago that Pharmaceutical Executive started to dig deeper into its biotech brethren that was fueling the innovation and inspiration for advanced science and therapeutic ingenuity.
In 2018, we
The numbers haven’t changed all that much, according to the recent
Based on their weighted rankings, JLL experts listed their top 15 life sciences clusters, consistent with our top five hubs above, adding Greater DC/Baltimore at No. 4; Raleigh-Durham, NC, at No. 6; Seattle at No. 9; and Salt Lake City at No. 10.
A shout-out to Philadelphia, however, for its recent No. 2 placement if you are looking at the cell and gene therapy (CGT) market. As noted in our 2018 article, state and local investment into building “Cellicon Valley” is hitting its stride. A recent
In this month’s issue, we do focus a bit on the current financial environment affecting biotech markets, as well as pharma M&As. Columnist Barbara Ryan
JLL experts also expect large biopharmas to play an outsized role in the funding and acquisitions space, as they sit atop a mountain of cash, though they expect “further belt-tightening” into 2023. It seems the overall sentiment is that even as the innovation engine takes a licking, it keeps on ticking.
Lisa Henderson is Pharm Exec’s Group Editorial Director. She can be reached at
Articles in this issue
almost 3 years ago
Healthy Planet, Healthy People: How Pharma Can Lead the Wayalmost 3 years ago
At the Heart of Pharma: ESG has Arrived as a Central Strategyalmost 3 years ago
Discerning Dealmaking: Caution Flag Still Raised in Biopharma M&A Racealmost 3 years ago
Keeping it Simplealmost 3 years ago
All About the Rates: The Fallout of Fed Hikes for Biotechalmost 3 years ago
Exploring Fixed and Variable Coverage Principlesalmost 3 years ago
Inclusion Check-In: Who are You Giving Your Energy To?almost 3 years ago
Cracking the Code to Commercial Promise in Asiaalmost 3 years ago
Push for Full Embrace of Digital Care Draws Opposition in Europealmost 3 years ago
Seeking Harmonized Testing, Regulation, and ManufacturingNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.